Search results
Results From The WOW.Com Content Network
All people with a GFR <60 mL/min/1.73 m 2 for 3 months are defined as having chronic kidney disease. [62] Protein in the urine is regarded as an independent marker for the worsening of kidney function and cardiovascular disease. Hence, British guidelines append the letter "P" to the stage of chronic kidney disease if protein loss is significant.
Proteinuria of greater than 3.5 g /24 h /1.73 m 2 (between 3 and 3.5 g/24 h /1.73 m 2 is considered to be proteinuria in the nephrotic range) or greater than 40 mg/h/m 2 in children. [9] [10] The ratio between urinary concentrations of albumin and creatinine can be used in the absence of a 24-hour urine test for total protein. This coefficient ...
Chyluria, also called chylous urine, is a medical condition involving the presence of chyle in the urine stream, [1] which results in urine appearing milky white. [2] The condition is usually classified as being either parasitic or non parasitic. It is a condition that is more prevalent among people of Africa and the Indian subcontinent.
However, most people don’t experience any symptoms of the condition. Prediabetes isn’t usually discovered until someone gets tested for the condition. Prediabetes increases your risk of:
It is more common in men (with a male-to-female ratio of up to 2:1). [2] It is most commonly diagnosed in the elderly (especially in people over 75 years of age). [3] Initial treatment is most commonly either partial or complete removal of the affected kidney(s). [4]
The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web.
The goal is to increase the urine volume because the concentration of cystine in the urine is reduced which prevents cystine from precipitating from the urine and forming stones. People with cystine stones should consume 5 to 7 liters a day. The rationale behind alkalizing the urine is that cystine tends to stay in solution and causes no harm.
The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study in patients with high-risk non-muscle invasive bladder cancer (NMIBC ...